Clinical Trial Update: The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating reduced-dose radiotherapy for HPV-positive oropharyngeal cancer has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hpv-positive Oropharyngeal Cancer
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Squamous Cell Carcinomas | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-09-01